Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1975 Jul 1;142(1):224–229. doi: 10.1084/jem.142.1.224

Studies on the selective lysis and purification of Trypanosoma cruzi

PMCID: PMC2189871  PMID: 807672

Abstract

The mechanism by which culture forms of Trypanosoma cruzi are lysed by normal mammalian sera was examined. Lysis is restricted to the epimastigote form of the organism and is not dependent on the presence of agglutinins. Lysis is a complement-dependent process, the activity being generated by the alternate pathway. The selective lysis by serum was exploited to purify viable trypomastigotes by means of centrifugation in an albumin column. Essentially pure trypomastigote populations are now being employed in cell culture experiments.

Full Text

The Full Text of this article is available as a PDF (367.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anziano D. F., Dalmasso A. P., Lelchuk R., Vásquez C. Role of complement in immune lysis of Trypanosoma cruzi. Infect Immun. 1972 Nov;6(5):860–864. doi: 10.1128/iai.6.5.860-864.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BONE G. J., PARENT G. Stearic acid, an essential growth factor for Trypanosoma cruzi. J Gen Microbiol. 1963 May;31:261–266. doi: 10.1099/00221287-31-2-261. [DOI] [PubMed] [Google Scholar]
  3. Budzko D. B., Pizzimenti M. C., Kierszenbaum F. Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Infect Immun. 1975 Jan;11(1):86–91. doi: 10.1128/iai.11.1.86-91.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Götze O., Müller-Eberhard H. J. The C3-activator system: an alternate pathway of complement activation. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s–108s. [PubMed] [Google Scholar]
  5. HIRSCH J. G. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med. 1960 Jul 1;112:15–22. doi: 10.1084/jem.112.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  7. PILLEMER L., BLUM L., LEPOW I. H., WURZ L., TODD E. W. The properdin system and immunity. III. The zymosan assay of properdin. J Exp Med. 1956 Jan 1;103(1):1–13. doi: 10.1084/jem.103.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. RUBIO M. Actividad lítica de sueros normales sobre formas de cultivo y sanguíneas de Trypanosoma cruzi. Bol Chil Parasitol. 1956 Oct-Dec;11(4):62–69. [PubMed] [Google Scholar]
  9. TOBIE E. J., VON BRAND T., MEHLMAN B. Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense. J Parasitol. 1950 Feb;36(1):48–54. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES